Literature DB >> 21232649

Pandemrix°, (H1N1)v influenza and reported cases of narcolepsy.

Jean-Louis Montastruc, Geneviève Durrieu, Olivier Rascol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21232649     DOI： 10.1016/j.vaccine.2010.12.092

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  7 in total

Review 1.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Vaccination and the onset of dravet syndrome.

Authors:  Elinor Ben-Menachem
Journal:  Epilepsy Curr       Date:  2011-07       Impact factor: 7.500

Review 3.  Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.

Authors:  Andrew J Broadbent; Kanta Subbarao
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

4.  Incidence of adverse events among healthcare workers following H1N1 Mass immunization in Ghana: a prospective study.

Authors:  Daniel N A Ankrah; Aukje K Mantel-Teeuwisse; Marie L De Bruin; Philip K Amoo; Charles N Ofei-Palm; Irene Agyepong; Hubert G M Leufkens
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

5.  Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.

Authors:  Markku Partinen; Outi Saarenpää-Heikkilä; Ismo Ilveskoski; Christer Hublin; Miika Linna; Päivi Olsén; Pekka Nokelainen; Reija Alén; Tiina Wallden; Merimaaria Espo; Harri Rusanen; Jan Olme; Heli Sätilä; Harri Arikka; Pekka Kaipainen; Ilkka Julkunen; Turkka Kirjavainen
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

6.  Estimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada.

Authors:  David N Fisman; Ashleigh R Tuite
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

7.  Towards universal influenza vaccines?

Authors:  Ab Osterhaus; Ron Fouchier; Guus Rimmelzwaan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.